{"doi":"10.1517/14656566.2011.546347","title":"Biologic properties and clinical uses of rifaximin","abstract":null,"journal":"Expert Opinion on Pharmacotherapy","year":2011,"id":672458,"datarank":0.5676284450877392,"base_score":3.784189633918261,"endowment":3.784189633918261,"self_citation_contribution":0.5676284450877392,"citation_network_contribution":0.0,"self_endowment_contribution":0.5676284450877392,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":43,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1756943,"name":"Herbert L DuPont","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Biologic properties and clinical uses of rifaximin","abstract":"INTRODUCTION: Rifaximin is increasingly being used to treat acute and chronic gastrointestinal infections and disorders. The drug exerts its beneficial effect through a variety of gut-selective mechanisms involving the host intestinal microbiota. AREAS COVERED: Abstracts of all publications listed in PubMed on the topic of rifaximin are reviewed to determine their potential value in the understanding of mechanisms of rifaximin activity. The author's extensive file on the drug is also used in the review. EXPERT OPINION: Rifaximin inhibits a broad spectrum of bacteria in the bile-rich small bowel and susceptible bacteria in the aqueous colon, and alters microbial virulence and epithelial cell function. The different mechanisms of action of rifaximin potentially explain the use of the drug in widely varied diseases and syndromes.","is_dataset_classified":null,"base_score":3.784189633918261,"endowment":3.784189633918261,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"21226639","pmcid":null,"openalex_id":"https://openalex.org/W2060728486","authors":[],"funders":[],"total_grants":0,"fwci":4.2994,"citation_percentile":0.93640553,"influential_citations":0,"citation_trend":[{"year":2012,"count":2},{"year":2013,"count":5},{"year":2014,"count":5},{"year":2015,"count":3},{"year":2016,"count":6},{"year":2017,"count":2},{"year":2018,"count":5},{"year":2019,"count":3},{"year":2021,"count":5},{"year":2022,"count":2},{"year":2025,"count":2},{"year":2026,"count":1}],"oa_status":"closed","license":null,"oa_locations":[{"url":"http://www.tandfonline.com/doi/pdf/10.1517/14656566.2011.546347","host_type":"publisher"},{"url":"https://doi.org/10.1517/14656566.2011.546347","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/21226639","host_type":"repository"}],"fields_of_study":["Travel-related health issues","Pneumocystis jirovecii pneumonia detection and treatment","Invertebrate Immune Response Mechanisms","Anti-Bacterial Agents","Bacterial Infections","Diarrhea","Enterotoxins","Epithelial Cells","Gastrointestinal Diseases","Gastrointestinal Tract","Hepatic Encephalopathy","Humans","Inflammation","Irritable Bowel Syndrome","Rifamycins","Rifaximin","Treatment Outcome"],"mesh_terms":["Rifaximin","Anti-Bacterial Agents","Bacterial Infections","Diarrhea","Enterotoxins","Epithelial Cells","Gastrointestinal Diseases","Hepatic Encephalopathy","Humans","Inflammation","Rifamycins","Treatment Outcome","Gastrointestinal Tract","Irritable Bowel Syndrome"],"keywords":["Rifaximin","Medicine","Gut flora","Drug","Irritable bowel syndrome","Antibiotics","Intensive care medicine","Bioinformatics","Pharmacology","Internal medicine","Microbiology","Immunology","Biology"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-16T09:10:33.777638Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}